Latest Pivotal bioVenture Partners Investment Advisor LLC Stock Portfolio
Pivotal bioVenture Partners Investment Advisor LLC Performance:
2024 Q3: 21.5%YTD: 45.07%2023: 3.01%
Performance for 2024 Q3 is 21.5%, and YTD is 45.07%, and 2023 is 3.01%.
About Pivotal bioVenture Partners Investment Advisor LLC and 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, Pivotal bioVenture Partners Investment Advisor LLC reported an equity portfolio of $168.5 Millions as of 30 Sep, 2024.
The top stock holdings of Pivotal bioVenture Partners Investment Advisor LLC are PCVX, INZY, ARQT. The fund has invested 43.4% of it's portfolio in VAXCYTE INC and 13.9% of portfolio in INOZYME PHARMA INC.
The fund managers got completely rid off ALIGOS THERAPEUTICS INC (ALGS) stocks. They significantly reduced their stock positions in VAXCYTE INC (PCVX). Pivotal bioVenture Partners Investment Advisor LLC opened new stock positions in ZENAS BIOPHARMA INC. The fund showed a lot of confidence in some stocks as they added substantially to ARCUTIS BIOTHERAPEUTICS INC (ARQT).
The top stock holdings of Pivotal bioVenture Partners Investment Advisor LLC are PCVX, INZY, ARQT. The fund has invested 43.4% of it's portfolio in VAXCYTE INC and 13.9% of portfolio in INOZYME PHARMA INC.
The fund managers got completely rid off ALIGOS THERAPEUTICS INC (ALGS) stocks. They significantly reduced their stock positions in VAXCYTE INC (PCVX). Pivotal bioVenture Partners Investment Advisor LLC opened new stock positions in ZENAS BIOPHARMA INC. The fund showed a lot of confidence in some stocks as they added substantially to ARCUTIS BIOTHERAPEUTICS INC (ARQT).
Pivotal bioVenture Partners Investment Advisor LLC Annual Return Estimates Vs S&P 500
Our best estimate is that Pivotal bioVenture Partners Investment Advisor LLC made a return of 21.5% in the last quarter. In trailing 12 months, it's portfolio return was 54.27%.
New Buys
| Ticker | $ Bought |
|---|---|
| zenas biopharma inc | 11,009,800 |
| bioage labs inc | 10,975,100 |
New stocks bought by Pivotal bioVenture Partners Investment Advisor LLC
Additions
| Ticker | % Inc. |
|---|---|
| arcutis biotherapeutics inc | 3.89 |
Additions to existing portfolio by Pivotal bioVenture Partners Investment Advisor LLC
Reductions
| Ticker | % Reduced |
|---|---|
| vaxcyte inc | -19.36 |
Pivotal bioVenture Partners Investment Advisor LLC reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| aligos therapeutics inc | -260,125 |
Pivotal bioVenture Partners Investment Advisor LLC got rid off the above stocks
Sector Distribution
Pivotal bioVenture Partners Investment Advisor LLC has about 73.1% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 73.1 |
| Others | 26.9 |
Market Cap. Distribution
Pivotal bioVenture Partners Investment Advisor LLC has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| MID-CAP | 43.4 |
| UNALLOCATED | 26.9 |
| SMALL-CAP | 25.7 |
| MICRO-CAP | 3.3 |
Stocks belong to which Index?
About 71.8% of the stocks held by Pivotal bioVenture Partners Investment Advisor LLC either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| RUSSELL 2000 | 71.8 |
| Others | 28.2 |
Pivotal bioVenture Partners Investment Advisor LLC Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Pivotal bioVenture Partners Investment Advisor LLC
Pivotal bioVenture Partners Investment Advisor LLC has 11 stocks in it's portfolio. RLYB proved to be the most loss making stock for the portfolio. PCVX was the most profitable stock for Pivotal bioVenture Partners Investment Advisor LLC last quarter.
Last Reported on: 13 Nov, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ALGS | aligos therapeutics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ARQT | arcutis biotherapeutics inc | 11.71 | 2,120,510 | 19,720,700 | added | 3.89 | ||
| BOLT | bolt biotherapeutics inc | 0.73 | 1,891,470 | 1,225,670 | unchanged | 0.00 | ||
| INZY | inozyme pharma inc | 13.95 | 4,494,850 | 23,508,100 | unchanged | 0.00 | ||
| IOBT | io biotech inc | 0.54 | 864,197 | 907,407 | unchanged | 0.00 | ||
| PCVX | vaxcyte inc | 43.38 | 639,539 | 73,080,100 | reduced | -19.36 | ||
| RLYB | rallybio corp | 1.67 | 2,404,640 | 2,813,430 | unchanged | 0.00 | ||
| VIGL | vigil neuroscience inc | 1.13 | 560,595 | 1,906,020 | unchanged | 0.00 | ||
| oculis holding ag | 11.61 | 1,595,920 | 19,566,000 | unchanged | 0.00 | |||
| zenas biopharma inc | 6.54 | 650,695 | 11,009,800 | new | ||||
| bioage labs inc | 6.51 | 527,647 | 10,975,100 | new | ||||
| exscientia plc | 2.23 | 770,500 | 3,760,040 | unchanged | 0.00 | |||